Skip to main content

Find Clinical Trials

Home
Conditions
Measles

Clinical trial condition

Measles

Explore clinical trials studying Measles. Study availability and eligibility vary by location and protocol.

101 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Measles trial results

Completed

Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds

NCT00892775

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Taipei, Taiwan

View Trial Details

Completed

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

NCT00092430

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Measles Vaccination Cash Incentives Experimental Evidence From Nigeria

NCT04013516

Conditions: Infections, Measles, Mononegavirales Infections, +4 more
Locations: All Babies are Equal Initiative (New Incentives) Abuja, Federal Capital Territory, Nigeria

View Trial Details

Completed

Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)

NCT00326183

Conditions: Chickenpox, DNA Virus Infections, Digestive System Diseases, +25 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)

NCT01536405

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

NCT00578175

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Tuscaloosa, Alabama, United States

GSK Investigational Site Phoenix, Arizona, United States

View all 141 locations

View Trial Details

Completed

Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children

NCT01506193

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Rome, Lazio, Italy

GSK Investigational Site Chiavari, Liguria, Italy

GSK Investigational Site Genoa, Liguria, Italy

GSK Investigational Site Milan, Lombardy, Italy

View all 13 locations

View Trial Details

Completed

ProQuad® Intramuscular vs Subcutaneous

NCT00402831

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

NCT00969436

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Bangalore, India

GSK Investigational Site Chennai, India

GSK Investigational Site Goā, India

GSK Investigational Site Kolkata, India

View Trial Details

Completed

Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

NCT00751348

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Bucheon-si, South Korea

GSK Investigational Site Daejeon, South Korea

GSK Investigational Site Gwangju, South Korea

GSK Investigational Site GyeongSangNam-do, South Korea

View all 13 locations

View Trial Details